Latest / Clinical Guideline InSights
AAP Prevention of Respiratory Syncytial Virus Disease in Infants and Children 2026 Policy Statement
The 2026 Prevention of Respiratory Syncytial Virus Disease in Infants and Children policy statement, highlighting key recommendations across approved products, timing of administration, coadministration with routine childhood vaccines, and more.
Prevention of Respiratory Syncytial Virus Disease in Infants and Children
American Academy of Pediatrics
September 2, 2026
Guideline Summary: https://www.guidelinecentral.com/guideline/5257391/
Full-Text: https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2026-079047/208784/Recommendations-for-the-Prevention-of-Respiratory
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.